CD
Psychiatrist
Stanford Univ Hosp, Psychiatry (Residency)
Stanford University Hospital (Residency)
Stanford University Medical Center CA (Internship)
Stanford University Medical Center (Residency)
Stanford University Medical Center CA (Fellowship)
Stanford University Program (Residency)
Other Degree - University of Ca, San Francisco, Sch of Med, San Francisco Ca
Medical Degree - University of California
American Board of Psychiatry and Neurology
American Board of Psychiatry and Neurology since 1995
conditions treated by a Psychiatrist, like Dr. Charles Debattista, may include:
Please contact Dr. Debattista's office for more information or to schedule a consultation.
procedures performed by a Psychiatrist, like Dr. Charles Debattista, may include:
For detailed information, please contact Dr. Debattista's office.
Aetna
Blue Cross Blue Shield (BCBS)
Bravo Health
Cigna
Humana Health
Medicaid
Medicare
UnitedHealthcare
View All Insurances
America's Best Doctors
Psychiatry, Best Doctors
Review Article of the Year, Primary Psychiatry
Teacher of the Year, Dept. Of Psychiatry
Measuring severe adverse events
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012
The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression
JOURL OF PSYCHIATRIC RESEARCH, 2011
Safety considerations of the use of second generation antipsychotics
Current drug safety, 2010
Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function
PSYCHONEUROENDOCRINOLOGY, 2009
A multisite trial of mifepristone for the treatment of psychotic depression
CONTEMPORARY CLINICAL TRIALS, 2009
Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression
CNS DRUGS, 2009
Sildefil treatment of women with antidepressant-associated sexual dysfunction - A r
JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2008
Depression and smoking cessation: does the evidence support psychiatric practice?
Neuropsychiatric disease and treatment, 2007
Modafinil augmentation of selective serotonin reuptake inhibitor therapy
Anls of clinical psychiatry, 2007
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major
BIOLOGICAL PSYCHIATRY, 2006
The neuropsychological profile of psychotic major depression and its relation to cortisol
BIOLOGICAL PSYCHIATRY, 2006
The efficacy of mifepristone in the reduction
BEHAVIOURAL BRAIN RESEARCH, 2006
Augmentation and combition strategies for depression
JOURL OF PSYCHOPHARMACOLOGY, 2006
The use of mifepristone in the treatment of neuropsychiatric disorders
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006
Modafinil augmentation of SSRI therapy in patients with major depressive disorder
CNS SPECTRUMS, 2006
Detecting psychotic major depression using psychiatric rating scales
JOURL OF PSYCHIATRIC RESEARCH, 2006
Update on augmentation of antidepressant response in resistant depression.
Current psychiatry reports, 2005
The efficacy of divalproex sodium in the treatment of agitation associated with major depression
JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2005
A placebo-controlled, randomized
JOURL OF CLINICAL PSYCHIATRY, 2005
C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.
Current Alzheimer research, 2005
Executive dysfunction in major depressive disorder.
Expert review of neurotherapeutics, 2005
A multicenter, placebo
JOURL OF CLINICAL PSYCHIATRY, 2005
HPA axis activation in major depression and response to fluoxetine: a pilot study
PSYCHONEUROENDOCRINOLOGY, 2004
A prospective trial of modafinil as an adjunctive treatment of major depression
JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2004
Seizure duration with remifentanil
ACTA AESTHESIOLOGICA SCANDIVICA, 2003
Adjunct modafinil for the short-term treatment of fatigue
JOURL OF CLINICAL PSYCHIATRY, 2003
Safety of antidepressants in the elderly.
Expert opinion on drug safety, 2003
A prospective trial of bupropion SR augmentation of partial
JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2003
The timing of electroconvulsive therapy
JOURL OF CLINICAL ANESTHESIA, 2003
Fetal heart rate decelerations during ECT-induced seizures: is it important?
ACTA AESTHESIOLOGICA SCANDIVICA, 2003
An open label trial of C-1073 (mifepristone) for psychotic major depression
BIOLOGICAL PSYCHIATRY, 2002
Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone
JOURL OF MOLECULAR NEUROSCIENCE, 2002
Cortisol feedback during the HPA quiescent period in patients with major depression
AMERICAN JOURL OF PSYCHIATRY, 2001
Is electroconvulsive therapy effective for the depressed patient
JOURL OF ECT, 2001
Sertraline versus imipramine to prevent relapse in chronic depression
JOURL OF AFFECTIVE DISORDERS, 2001
Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia
ANLS OF INTERL MEDICINE, 2001
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients
AMERICAN JOURL OF PSYCHIATRY, 2000
24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major
Posener, J. A., Debattista, C., Williams, G. H., Kraemer, H. C., Kaleh, 2000
Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness
AMERICAN JOURL OF PSYCHIATRY, 2000
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression
JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2000
Negative-pressure pulmory edema: A potential mazard in patients undergoing ECT
JOURL OF ECT, 1999
The Texas Medication Algorithm Project
JOURL OF CLINICAL PSYCHIATRY, 1999
Phenomenology and treatment of agitation
Schatzberg, A. F., Debattista, C., 1999
ECT in dissociative identity disorder and comorbid depression
JOURL OF ECT, 1998
Serotonergic synergism
BIOLOGICAL PSYCHIATRY, 1998
Developing treatment algorithms for unipolar depression in cyberspace
PSYCHOPHARMACOLOGY BULLETIN, 1998
Treatment of psychotic depression
AMERICAN JOURL OF PSYCHIATRY, 1997
Development of obsessive symptoms during nefazodone treatment
AMERICAN JOURL OF PSYCHIATRY, 1996
SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES
HEADACHE, 1995
PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL
AMERICAN JOURL OF PSYCHIATRY, 1995
YX
VC